Table 1 Clinical characteristics of the participants.
AN group (T1) n = 12 | AN group (T2) n = 12 | HC group n = 14 | P | Post-hoc analysis | |
---|---|---|---|---|---|
Age (month) | 160.2 (16.6) | 162.8 (17.7) | 172.1 (5.1) | 0.080 | |
Illness duration (month) | 7.0 (4.2) | ||||
Height (cm) | 153.8 (6.9) | 154.0 (7.2) | 157.4 (5.5) | 0.284 | |
Weight (kg) | 29.9 (5.4) | 37.7 (5.2) | 49.2 (5.4) | < 0.001 | T1 < T2, T1 < HC, T2 < HC |
%IBW | 64.1 (4.7) | 81.0 (1.6) | 98.3 (8.7) | < 0.001 | T1 < T2, T1 < HC, T2 < HC |
BMI | 13.1 (10.6–14.1) | 15.8 (14.2–16.9) | 19.8 (16.8–23.6) | < 0.001 | T1 < T2, T1 < HC, T2 < HC |
BMI-SDS | − 4.48 (0.98) | − 1.82 (0.23) | − 0.17 (0.66) | < 0.001 | T1 < T2, T1 < HC, T2 < HC |
DSRS-C | 17.7 (8.4) | 12.2 (6.5) | 7.8 (5.6) | 0.003 | T1 > HC |
SCAS | 48 (8–87) | 15.5 (2–73) | 17 (3–55) | 0.101 | |
ChEAT26 | 38 (7–53) | 14 (4–59) | 8 (2–30) | < 0.001 | T1 > HC |
EDE-Q-J | 2.68 (1.60) | 1.98 (1.79) | 1.06 (0.81) | 0.02 | T1 > HC |